<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Retispec on Bioecon</title><link>https://en.bioecon.ru/companies/retispec/</link><description>Recent content in Retispec on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 17:39:16 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/retispec/index.xml" rel="self" type="application/rss+xml"/><item><title>Retinal biomarkers for neurodegenerative disease</title><link>https://en.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/</guid><description>Eye-scan technologies that detect Alzheimer&amp;rsquo;s and other neurodegenerative-disease biomarkers directly in the retina — a window onto brain pathology accessible without imaging the brain itself — spanning hyperspectral imaging, OCT-based structural biomarkers and retinal amyloid detection: RetiSpec and NeuroVision Imaging in North America, Optina Diagnostics in Canada, and Heidelberg Engineering in Germany.</description></item></channel></rss>